Cosmos Health Stock Alpha and Beta Analysis
| COSM Stock | USD 0.66 0.07 9.59% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Cosmos Health. It also helps investors analyze the systematic and unsystematic risks associated with investing in Cosmos Health over a specified time horizon. Remember, high Cosmos Health's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Cosmos Health's market risk premium analysis include:
Beta 0.66 | Alpha (0.11) | Risk 5.81 | Sharpe Ratio 0.0115 | Expected Return 0.0667 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Cosmos |
Cosmos Health Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Cosmos Health market risk premium is the additional return an investor will receive from holding Cosmos Health long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Cosmos Health. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Cosmos Health's performance over market.| α | -0.11 | β | 0.66 |
Cosmos Health expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Cosmos Health's Buy-and-hold return. Our buy-and-hold chart shows how Cosmos Health performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Cosmos Health Market Price Analysis
Market price analysis indicators help investors to evaluate how Cosmos Health stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cosmos Health shares will generate the highest return on investment. By understating and applying Cosmos Health stock market price indicators, traders can identify Cosmos Health position entry and exit signals to maximize returns.
Cosmos Health Return and Market Media
The median price of Cosmos Health for the period between Sat, Nov 2, 2024 and Fri, Jan 31, 2025 is 0.72 with a coefficient of variation of 9.06. The daily time series for the period is distributed with a sample standard deviation of 0.07, arithmetic mean of 0.72, and mean deviation of 0.05. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | ARMISTICE CAPITAL, LLC Acquires New Stake in Cosmos Health Inc | 11/15/2024 |
2 | Cosmos Health Third Quarter 2024 Earnings Misses Expectations | 11/18/2024 |
3 | Taglich Brothers Releases Updated Coverage on Cosmos Health Projects Positive EPS for 2025 and Sets 3 Price Target, Nearly 300 percent Above Current Share Price | 11/26/2024 |
4 | Disposition of 42500 shares by Grigorios Siokas of Cosmos Health at 0.28 subject to Rule 16b-3 | 12/06/2024 |
5 | Acquisition by Grigorios Siokas of 257334 shares of Cosmos Health at 0.5829 subject to Rule 16b-3 | 12/20/2024 |
6 | Cosmos Health Inc. CFO Georgios Terzis Purchases 85,778 Shares | 12/27/2024 |
7 | Acquisition by Grigorios Siokas of 4474 shares of Cosmos Health at 23.92 subject to Rule 16b-3 | 01/06/2025 |
8 | Cosmos Health announces distribution agreement with Virax Biolabs | 01/13/2025 |
9 | Acquisition by Grigorios Siokas of 87247 shares of Cosmos Health at 0.6877 subject to Rule 16b-3 | 01/14/2025 |
10 | Acquisition by Grigorios Siokas of 47904 shares of Cosmos Health at 0.835 subject to Rule 16b-3 | 01/16/2025 |
11 | Cosmos Health CEO Greg Siokas Acquires a Total of 647,809 Shares Valued at 425,000 Over the Past 32 Days | 01/21/2025 |
12 | Acquisition by Grigorios Siokas of 38900 shares of Cosmos Health at 0.7712 subject to Rule 16b-3 | 01/22/2025 |
13 | Cosmos Health Files AI-Powered Patent for Revolutionary Allergy Treatment - StockTitan | 01/27/2025 |
About Cosmos Health Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Cosmos or other stocks. Alpha measures the amount that position in Cosmos Health has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2022 | 2024 | 2025 (projected) | Dividend Yield | 3.64 | 3.28 | 3.44 | Price To Sales Ratio | 0.17 | 0.36 | 0.35 |
Cosmos Health Upcoming Company Events
As portrayed in its financial statements, the presentation of Cosmos Health's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Cosmos Health's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Cosmos Health's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Cosmos Health. Please utilize our Beneish M Score to check the likelihood of Cosmos Health's management manipulating its earnings.
| 11th of April 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with Cosmos Health
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Cosmos Health Backtesting, Cosmos Health Valuation, Cosmos Health Correlation, Cosmos Health Hype Analysis, Cosmos Health Volatility, Cosmos Health History and analyze Cosmos Health Performance. To learn how to invest in Cosmos Stock, please use our How to Invest in Cosmos Health guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Cosmos Health technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.